| 摘要 |
A pharmaceutical composition comprises a synergistic combination of at least about 0.01 % by wt. triamcinolone acetonide and at least about 0.01 % by wt. halcinonide as active ingredients therein, in combination with a pharmaceutically acceptable carrier for treating psoriasis or eczema, dermatitis. rosacea and/or other similar dermatological conditions.
|
